Royalty Pharma plc (RPRX) announced earnings for its fourth quarter that Increased from the same period last year
The company's earnings totaled $214 million. This compares with $208 million last year.
The company's revenue for the period rose 4.7% to $622 million from $594 million last year.
Royalty Pharma plc earnings at glance (GAAP):
-Earnings: $214 Mln. vs. $208 Mln. last year.-Revenue: $622 Mln vs. $594 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.